Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Squamous cell carcinomas, an immunohistochemical and ultrastructural study.

Z Suo1, R Holm, J M Nesland

  • 1Department of Pathology, Norwegina Radium Hospital, Oslo.

Anticancer Research
|November 1, 1992
PubMed
Summary

This study investigated squamous cell carcinomas (SCCs), finding p53 protein overexpression in 40% of primary tumors and 60% of metastases. Some SCCs showed specific cytokeratin and vimentin expression, indicating potential diagnostic markers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'Is Oral Absorption of Vigabatrin Carrier-mediated?' [European Journal of Pharmaceutical Sciences 69 (2015) 10-18].

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2021
Same author

Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2021
Same author

Six years of progress in the oral biopharmaceutics area - A summary from the IMI OrBiTo project.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2020
Same author

Solution or suspension - Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2017
Same author

A survey on IVIVC/IVIVR development in the pharmaceutical industry - Past experience and current perspectives.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2017
Same author

Is oral absorption of vigabatrin carrier-mediated?

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2015

Area of Science:

  • Oncology
  • Pathology
  • Molecular Biology

Background:

  • Squamous cell carcinomas (SCCs) are common malignancies with varied differentiation.
  • Understanding SCC protein expression aids in diagnosis and prognosis.
  • Specific cytokeratins and intermediate filaments are key cellular markers.

Purpose of the Study:

  • To analyze the expression of CAM5.2, cytokeratins 6 and 18, c-erbB2, p53, and vimentin in SCCs.
  • To correlate protein expression with tumor differentiation and metastatic potential.
  • To identify potential immunohistochemical markers for SCC diagnosis.

Main Methods:

  • Light microscopy, immunohistochemistry, and electron microscopy were employed.
  • Antibodies against CAM5.2, cytokeratins 6 and 18, c-erbB2, p53, and vimentin were used.

Related Experiment Videos

  • Analysis included 47 cases of SCCs from various locations.
  • Main Results:

    • Nineteen percent of SCCs expressed CAM5.2.
    • Three poorly differentiated SCCs lacked cytokeratins 6 and 18.
    • p53 overexpression was observed in 40% of primary tumors and 60% of lymph node metastases.
    • Vimentin expression was noted in four poorly differentiated SCCs with cytoplasmic intermediate filament accumulation.

    Conclusions:

    • p53 overexpression is frequent in SCCs, particularly in metastatic lesions.
    • Expression patterns of CAM5.2, cytokeratins, and vimentin may offer insights into SCC biology.
    • Immunohistochemistry can help characterize SCCs and potentially predict behavior.